This body of evidence, given its generation largely in small animal- and cell culture-based models, is suggestive, but not sufficient
Youre not introducing a pharmaceutical compound that mimics GLP-1
What can get lost in the fog of information is that certain peptides have solid research behind themlike GLP-1 medicationswhile others are riding on the tail of GLP-1 meds success
Key research themes involving glutathione include: Scavenging of free radicals (e.g., peroxides, nitrogen dioxide, hypochlorous acid) Support of other antioxidant systems (e.g., vitamin C and vitamin E recycling) Detoxification via glutathione S-transferases and related enzymes Regulation of protein folding, disulfide-bond formation, and thiol redox status Modulation of inflammatory mediators, nitric oxide pathways, and cellular metabolism Because endogenous glutathione synthesis capacity appears to decrease with age in many models, glutathione is frequently used as both an experimental variable and a biomarker in studies of aging, disease susceptibility, and redox imbalance
correlation between COVID-19 and viral-induced ROS in lung/respiratory epithelium during this pandemic
